Researchers create much-needed medical isotopes

July 9, 2015, National Physical Laboratory
Researchers create much-needed medical isotopes

No one likes to see leftovers go to waste, and especially not nuclear physicists. Now the National Physical Laboratory (NPL) is helping to get the recipe right. The Radioactivity Group at NPL is supporting the nuclear physics facility at CERN with a new project to redesign the beam dump so that the 'wasted' protons can be used for manufacturing radiopharmaceuticals for diagnostic imaging.

Great effort goes into generating the that are the focus of research at CERN's world-leading ISOLDE nuclear physics facility, but only about 10 % of the proton beam is stopped by the target, leaving 90 % to be absorbed by a beam dump. To the ISOLDE nuclear physicists, this seemed like a terrible waste, particularly as there is a widespread shortage of medical to diagnose and treat diseases.

The MEDICIS project, which was first announced in 2012, will make radioisotopes for medical applications by utilising these unused . An additional target downstream of the first target, allows isotopes to be generated without interrupting the experimental schedule.

Initially, the facility will produce small batches of radioisotopes for research at institutions local to CERN, including two university hospitals and the cancer research institute at the École Polytechnique Fédérale de Lausanne, although there is a view of expanding to create a larger world-wide network of laboratories. The ISOLDE collaboration has already completed test collections of isotopes and shipped them to the university hospital in Lausanne.

NPL will be helping MEDICIS meet the Good Manufacturing Practice (GMP) criteria. GMP is the minimum standard that medicines manufacturers must meet in their production processes. Any new product must undergo clinical trials and toxicology studies to demonstrate that every manufactured batch will be consistent with the samples used in clinical trials.

NPL will be contributing reference materials and calibration sources, loaning equipment, and providing expertise to help with radiochemical separation and calibration.

Steven Judge, Group Leader of NPL's Radioactivity team, said:

"It's a really interesting project. We're keen to contribute to the issue of medical isotope production to support the growth in the use of these isotopes for diagnostic studies and for cancer therapy.

"We'll also be helping MEDICIS with the measurement protocols and compliance documentation for the isotopes. I'm very excited to be working with CERN; NPL's mission is to enable accurate measurement and MEDICIS fits very well with our mission."

Explore further: CERN: A milestone toward a higher-energy nuclear physics facility

Related Stories

Recommended for you

Coffee-based colloids for direct solar absorption

March 22, 2019

Solar energy is one of the most promising resources to help reduce fossil fuel consumption and mitigate greenhouse gas emissions to power a sustainable future. Devices presently in use to convert solar energy into thermal ...

Physicists reveal why matter dominates universe

March 21, 2019

Physicists in the College of Arts and Sciences at Syracuse University have confirmed that matter and antimatter decay differently for elementary particles containing charmed quarks.

ATLAS experiment observes light scattering off light

March 20, 2019

Light-by-light scattering is a very rare phenomenon in which two photons interact, producing another pair of photons. This process was among the earliest predictions of quantum electrodynamics (QED), the quantum theory of ...

How heavy elements come about in the universe

March 19, 2019

Heavy elements are produced during stellar explosion or on the surfaces of neutron stars through the capture of hydrogen nuclei (protons). This occurs at extremely high temperatures, but at relatively low energies. An international ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.